Calprotectin (a major leucocyte protein) is associated with the levels of anti‐CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis

References

• Foell D., Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004; 50: 3762–71
   PubMed Web of Science ®Google Scholar
• Odink K., Cerletti N., Bruggen J., Clerc R. G., Tarcsay L., Zwadlo G., et al. Two calcium‐binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330: 80–2
   PubMed Web of Science ®Google Scholar
• Wilkinson M. M., Busuttil A., Hayward C., Brock D. J. H., Dorin J. R., van Heyningen V. Expression pattern of two related cystic fibrosis‐associated calcium‐binding proteins in normal and abnormal tissues. J Cell Sci 1988; 91: 221–30
   PubMed Web of Science ®Google Scholar
• Berntzen H. B., Munthe E., Fagerhol M. K. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989; 16: 1416–20
   PubMed Web of Science ®Google Scholar
• Brun J. G., Haga H‐J., Boe E., Kallay I., Lekven C., Berntzen H. B., et al. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol 1992; 19: 859–62
   PubMed Web of Science ®Google Scholar
• Youssef P., Roth J., Frosch M., Costello P., Fitzgerald O., Sorg C., et al. Expression of myeloid related proteins (MRP)8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 1999; 26: 2523–8
   PubMed Web of Science ®Google Scholar
• Frosch M., Strey A., Vogl T., Wulffraat N. M., Kuis W., Sunderkotter C., et al. Myeloid‐related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular‐onset juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 628–37
   PubMed Web of Science ®Google Scholar
• Berntzen H. B., Olmez U., Fagerhol M. K., Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1991; 20: 74–82
   PubMed Web of Science ®Google Scholar
• Hammer H. B., Ødegaard S., Fagerhol M. K., Landewe R., van der Heijde D., Uhlig T., et al. Calprotectin (a major leukocyte protein) is strongly and independently correlated to joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1093–7
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Kristinsson J., Roseth A., Fagerhol M. K., Aadland E., Schjonsby H., Bormer O. P., et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998; 41: 316–21
   PubMed Web of Science ®Google Scholar
• Syversen S. W., Gaarder P. I., Goll G. L., Ødegaard S., Haavardsholm E. A., Mowinckel P., et al. High anti‐CCP levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10‐year longitudinal study. Ann Rheum Dis 2008; 67: 212–7
   PubMed Web of Science ®Google Scholar
• Kroot E‐J. J. A., de Jong B. A. W., van Leeuwen M. A., Swinkels H., van den Hoogen F. H. J., van't Hof M., et al. The prognostic value of anti‐cyclic citrullinated peptide antibody in patients with recent‐onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831–5
   PubMed Web of Science ®Google Scholar
• van Gaalen F. A., Linn‐Rasker S. P., van Venrooij W. J., de Jong B. A., Breedveld F. C., Verweij C. L., et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis. A prospective cohort study. Arthritis Rheum 2004; 50: 709–15
   PubMed Web of Science ®Google Scholar
• Bas S., Genevay S., Meyer O., Gabay C. Anti‐cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 2003; 42: 677–80
   PubMed Web of Science ®Google Scholar